NovoCure Limited
DE ˙ DB ˙ JE00BYSS4X48
13,66 € ↑0,85 (6,63%)
2026-06-04
AKTIENPREIS
SecurityDE:038 / NovoCure Limited
InstitutionSei Investments Co
Latest Disclosed Ownership24,442 shares
Latest Disclosed Value $ 316,039
Sei Investments Co reports 6.02% decrease in ownership of 038 / NovoCure Limited

On February 13, 2026 - Sei Investments Co filed a 13F-HR form disclosing ownership of 24,442 shares of NovoCure Limited (DE:038) valued at $267,884 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 13, 2025 disclosing 26,009 shares of NovoCure Limited. This represents a change in shares of -6.02% during the quarter. The current value of the position is $334,000 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-02-13 2025-12-31 13F NOVOCURE ORD SHS G6674U108 24,442 -1,567 -6.02 316 -5.95 0.0003
2025-11-13 2025-09-30 13F NOVOCURE ORD SHS G6674U108 26,009 8,487 48.44 336 8.04 0.0004
2025-08-14 2025-06-30 13F NOVOCURE ORD SHS G6674U108 17,522 17,522 312 0.0004
2023-08-11 2023-06-30 13F NOVOCURE ORD SHS G6674U108 0 -6,483 -100.00 0 -100.00
2023-05-12 2023-03-31 13F NOVOCURE ORD SHS G6674U108 6,483 3,434 112.63 390 74.44 0.0007
2023-02-10 2022-12-31 13F NOVOCURE ORD SHS G6674U108 3,049 -129 -4.06 224 -7.47 0.0005
2022-11-14 2022-09-30 13F NOVOCURE ORD SHS G6674U108 3,178 -298 -8.57 241 5.24 0.0005
2022-08-15 2022-06-30 13F NOVOCURE ORD SHS G6674U108 3,476 -238 -6.41 229 -25.16 0.0005
2022-05-13 2022-03-31 13F NOVOCURE ORD SHS G6674U108 3,714 84 2.31 306 12.09 0.0006
2022-02-14 2021-12-31 13F NOVOCURE ORD SHS G6674U108 3,630 607 20.08 273 -22.00 0.0005
2021-11-12 2021-09-30 13F NOVOCURE ORD SHS G6674U108 3,023 -62 -2.01 350 -48.83 0.0007
2021-08-06 2021-06-30 13F NOVOCURE ORD SHS G6674U108 3,085 -6,732 -68.57 684 -47.30 0.0015
2021-05-12 2021-03-31 13F NOVOCURE ORD SHS G6674U108 9,817 -3,685 -27.29 1,298 -44.43 0.0033
2021-02-08 2020-12-31 13F NOVOCURE ORD SHS G6674U108 13,502 -6,711 -33.20 2,336 3.23 0.0060
2020-12-04 2020-09-30 13F/A-1 NOVOCURE ORD SHS G6674U108 20,213 -24,703 -55.00 2,263 -15.02 0.0066
2020-11-06 2020-09-30 13F NOVOCURE ORD SHS G6674U108 21,563 -23,353 2,413 5,809.9675
2020-08-17 2020-06-30 13F/A-1 NOVOCURE ORD SHS G6674U108 44,916 10,734 31.40 2,663 15.68 0.0083
2020-08-11 2020-06-30 13F NOVOCURE ORD SHS G6674U108 29,778 -4,404 2,468 6,694.5814
2020-05-14 2020-03-31 13F NOVOCURE ORD SHS G6674U108 34,182 6,028 21.41 2,302 -2.99 0.0085
2020-02-06 2019-12-31 13F NOVOCURE ORD SHS G6674U108 28,154 -5,883 -17.28 2,373 -8.94 0.0071
2019-11-12 2019-09-30 13F NOVOCURE ORD SHS G6674U108 34,037 -9,416 -21.67 2,606 -2.87 0.0067
2019-08-14 2019-06-30 13F NOVOCURE ORD SHS G6674U108 43,453 -4,914 -10.16 2,683 15.15 0.0088
2019-05-15 2019-03-31 13F NOVOCURE ORD S3 G6674U108 48,367 -11,894 -19.74 2,330 -26.22 0.0078
2019-02-13 2018-12-31 13F NOVOCURE ORD SHS G6674U108 60,261 0 0.00 3,158 0.00 0.0112
2018-11-08 2018-09-30 13F NOVOCURE ORD SHS G6674U108 60,261 -13,662 -18.48 3,158 36.47 0.0114
2018-08-03 2018-06-30 13F NOVOCURE ORD SHS G6674U108 73,923 55,000 290.65 2,314 461.65 0.0079
2018-05-11 2018-03-31 13F NOVOCURE ORD SHS G6674U108 18,923 8 0.04 412 7.85 0.0016
2018-02-08 2017-12-31 13F NOVOCURE ORD SHS G6674U108 18,915 -1,095 -5.47 382 -3.78 0.0013
2017-11-06 2017-09-30 13F NOVOCURE ORD SHS G6674U108 20,010 20,010 397 0.0014
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.